ASLAN Pharmaceuticals (ASLN) Short Interest Ratio & Short Volume → Dems have chosen Biden replacement? (From Paradigm Press) (Ad) Free ASLN Stock Alerts $0.41 -0.01 (-2.38%) (As of 05/10/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media ASLAN Pharmaceuticals Short Interest DataCurrent Short Volume700,400 sharesPrevious Short Volume250,200 sharesChange Vs. Previous Month+179.94%Dollar Volume Sold Short$322,184.00Short Interest Ratio / Days to Cover0.6Last Record DateApril 30, 2024Outstanding Shares16,350,000 sharesFloat Size16,990,000 sharesShort Percent of Float4.12%Today's Trading Volume162,229 sharesAverage Trading Volume900,216 sharesToday's Volume Vs. Average18% Short Selling ASLAN Pharmaceuticals ? Sign up to receive the latest short interest report for ASLAN Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatASLN Short Interest Over TimeASLN Days to Cover Over TimeASLN Percentage of Float Shorted Over Time Ad Porter & CompanyObama’s Forever Term [exposed]America’s Last Election New documentary, America’s Last Election, reveals the true (and terrifying) story of how the D.C. establishment has engineered a brutal new crisis that could hand them permanent power. Power they will use to reshape America to their dark, dystopian vision.Start streaming it now at no cost here ASLAN Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024700,400 shares $322,184.00 +179.9%4.1%0.6 $0.46 4/15/2024250,200 shares $126,426.06 +114.2%1.5%0.2 $0.51 3/31/2024116,800 shares $71,855.36 -59.8%0.7%0.1 $0.62 3/15/2024290,500 shares $188,825.00 +1,405.2%1.8%0.3 $0.65 2/29/202419,300 shares $16,984.00 -38.3%0.1%0 $0.88 2/15/202431,300 shares $17,625.03 -46.7%0.2%0.1 $0.56 Get the Latest News and Ratings for ASLN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ASLAN Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/202458,700 shares $40,062.75 +9.3%0.4%0.3 $0.68 1/15/202453,700 shares $50,773.35 -24.4%0.3%0.3 $0.95 12/31/202371,000 shares $37,069.10 +203.4%0.4%0.5 $0.52 12/15/202323,400 shares $13,525.20 -31.4%0.2%0.2 $0.58 11/30/202334,100 shares $23,535.82 -19.2%0.2%0.6 $0.69 11/15/202342,200 shares $43,044.00 +20.9%0.3%1.3 $1.02 10/31/202334,900 shares $38,390.00 +3.6%0.3%1.4 $1.10 10/15/202333,700 shares $43,136.00 -32.2%0.2%1.3 $1.28 9/30/202349,700 shares $93,436.00 -78.3%0.4%1.4 $1.88 9/15/2023228,600 shares $448,056.00 -6.5%1.7%2.2 $1.96 8/31/2023244,500 shares $519,562.50 -20.9%1.8%2 $2.13 8/15/2023308,900 shares $651,779.00 -6.9%2.2%2.2 $2.11 7/31/2023331,600 shares $782,576.00 0.0%2.6%2.2 $2.36 7/15/2023331,700 shares $932,077.00 +203.8%2.6%2.2 $2.81 6/30/2023109,200 shares $398,580.00 +105.3%1.0%0.8 $3.65 6/15/202353,200 shares $212,268.00 +25.2%0.5%0.7 $3.99 5/31/202342,500 shares $170,000.00 -91.2%0.4%0.8 $4.00 5/15/2023483,800 shares $2.10 million +16.5%4.2%9.6 $4.35 4/30/2023415,400 shares $1.72 million +1.7%3.1%10.4 $4.15 4/15/2023408,300 shares $1.44 million +3.7%3.0%10.4 $3.53 3/31/2023393,700 shares $1.13 million +1.0%2.9%10.8 $2.88 3/15/2023389,900 shares $1.25 million -79.9%2.9%9.5 $3.20 2/28/20231,940,000 shares $1.46 million +1.0%2.9%10.9 $0.76 2/15/20231,920,000 shares $1.52 million -1.0%2.9%10.9 $0.79 1/31/20231,940,000 shares $1.33 million +3.2%2.9%11.2 $0.69 1/15/20231,880,000 shares $1.20 million No Change2.8%8.1 $0.64 12/30/20221,880,000 shares $676,800.00 -0.5%2.8%8.5 $0.36 12/15/20221,890,000 shares $869,400.00 No Change2.8%9.9 $0.46 11/30/20221,890,000 shares $1.04 million -3.6%2.8%9.9 $0.55 11/15/20221,960,000 shares $975,296.00 -1.0%2.9%9.5 $0.50 10/31/20221,980,000 shares $799,920.00 +3.7%3.0%8.6 $0.40 10/15/20221,910,000 shares $957,101.00 -3.1%2.9%12 $0.50 9/30/20221,970,000 shares $1.18 million +2.1%2.9%12.7 $0.60 9/15/20221,930,000 shares $1.45 million +4.9%2.9%11.1 $0.75Global crypto currency reset (41 major banks signed up) (Ad)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project... Here's everything you need to know. ASLN Short Interest - Frequently Asked Questions What is ASLAN Pharmaceuticals' current short interest? Short interest is the volume of ASLAN Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 700,400 shares of ASLN short. 4.12% of ASLAN Pharmaceuticals' shares are currently sold short. Learn More on ASLAN Pharmaceuticals' current short interest. What is a good short interest ratio for ASLAN Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ASLN shares currently have a short interest ratio of 1.0. Learn More on ASLAN Pharmaceuticals's short interest ratio. Which institutional investors are shorting ASLAN Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of ASLAN Pharmaceuticals: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for ASLAN Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.12% of ASLAN Pharmaceuticals' floating shares are currently sold short. Is ASLAN Pharmaceuticals' short interest increasing or decreasing? ASLAN Pharmaceuticals saw a increase in short interest in April. As of April 30th, there was short interest totaling 700,400 shares, an increase of 179.9% from the previous total of 250,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is ASLAN Pharmaceuticals' float size? ASLAN Pharmaceuticals currently has issued a total of 16,350,000 shares. Some of ASLAN Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ASLAN Pharmaceuticals currently has a public float of 16,990,000 shares. How does ASLAN Pharmaceuticals' short interest compare to its competitors? 4.12% of ASLAN Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to ASLAN Pharmaceuticals: Ainos, Inc. (2.12%), Kineta, Inc. (1.96%), Pulmatrix, Inc. (0.08%), Tenax Therapeutics, Inc. (1.20%), Enveric Biosciences, Inc. (1.07%), Shuttle Pharmaceuticals Holdings, Inc. (0.74%), TransCode Therapeutics, Inc. (2.29%), Processa Pharmaceuticals, Inc. (24.82%), Lixte Biotechnology Holdings, Inc. (1.31%), Adial Pharmaceuticals, Inc. (4.42%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short ASLAN Pharmaceuticals stock? Short selling ASLN is an investing strategy that aims to generate trading profit from ASLAN Pharmaceuticals as its price is falling. ASLN shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ASLAN Pharmaceuticals? A short squeeze for ASLAN Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ASLN, which in turn drives the price of the stock up even further. How often is ASLAN Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ASLN, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Ainos Short Interest Kineta Short Interest Pulmatrix Short Interest Tenax Therapeutics Short Interest Enveric Biosciences Short Interest Shuttle Pharmaceuticals Short Interest TransCode Therapeutics Short Interest Processa Pharmaceuticals Short Interest Lixte Biotechnology Short Interest Adial Pharmaceuticals Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ASLN) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe Crypto 9-5 Escape PlanCrypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldGold Set to EXPLODE!Gold Safe ExchangeGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press